January 17, 2017 9:05 AM ET

Biotechnology

Company Overview of Genocea Biosciences, Inc.

Key Executives for Genocea Biosciences, Inc.

NameBoard RelationshipsTitleAge
William D. Clark 15 RelationshipsChief Executive Officer, President and Director47
Darren Higgins Ph.D.15 RelationshipsScientific Co-Founder and Member of Scientific Advisory Board--
Jonathan Poole No RelationshipsChief Financial Officer and Secretary41
John E. Bishop Ph.D.No RelationshipsExecutive Vice President of Pharmaceutical Sciences54
Seth Hetherington M.D.No RelationshipsChief Medical Officer64
View More Key Executives

Genocea Biosciences, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Katrine S. Bosley 47 RelationshipsEditas Medicine, Inc.48
William D. Clark 15 RelationshipsGenocea Biosciences, Inc.47
Darren Higgins Ph.D. 15 RelationshipsGenocea Biosciences, Inc.--
George R. Siber M.D. 106 RelationshipsGenocea Biosciences, Inc.71
Kenneth M. Bate MBA 83 RelationshipsCatabasis Pharmaceuticals, Inc.66
View All Board Members

Genocea Biosciences, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Michael J. Higgins41 Relationships3 Executives
Compensation Committee MBAKenneth M. Bate83 Relationships3 Executives
Nominating Committee Katrine S. Bosley47 Relationships3 Executives
Corporate Governance Committee Katrine S. Bosley47 Relationships3 Executives
Advisory Board M.D.George R. Siber106 Relationships9 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$427.4K
427.4K
369.1K
Bonus
Not meaningful
Total Short Term Compensation
Not meaningful
Total Value of Options$427.4K
427.4K
34.4M
Compensation as of Fiscal Year 2015
Genocea Biosciences, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Bavarian Nordic A/S Appoints Henrik Birk as Chief Operating Officer
January 17, 2017 7:00 AM ET
InMed Pharmaceuticals Inc. Appoints Martin Bott to the Board of Directors
January 13, 2017 8:42 PM ET
Uni-Bio Science Group Limited Announces Executive Changes
January 13, 2017 11:38 AM ET
Bioscience Americas, LLC Appoints Shekhar K. Challa to Its Board of Advisors
January 13, 2017 11:30 AM ET
Nivalis Therapeutics, Inc. Announces Management Changes, with Effect from January 15, 2017
January 12, 2017 9:16 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Genocea Biosciences, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.